267 related articles for article (PubMed ID: 17803791)
1. Percutaneous radiofrequency ablation of renal tumours: case series of 11 tumours and review of published work.
Watkins TW; Parkinson R
Australas Radiol; 2007 Oct; 51(5):412-9. PubMed ID: 17803791
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P
Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
6. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
7. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens.
Park S; Strup SE; Saboorian H; Cadeddu JA
Urology; 2006 Nov; 68(5):964-7. PubMed ID: 17113888
[TBL] [Abstract][Full Text] [Related]
8. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of renal tumors in the solitary kidney.
Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
[TBL] [Abstract][Full Text] [Related]
10. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results.
Fotiadis NI; Sabharwal T; Morales JP; Hodgson DJ; O'Brien TS; Adam A
Eur Urol; 2007 Sep; 52(3):777-84. PubMed ID: 17400364
[TBL] [Abstract][Full Text] [Related]
11. Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works.
Carrafiello G; Laganà D; Ianniello A; Dionigi G; Novario R; Recaldini C; Mangini M; Cuffari S; Fugazzola C
Australas Radiol; 2007 Dec; 51(6):550-4. PubMed ID: 17958690
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
[TBL] [Abstract][Full Text] [Related]
13. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk.
Ukimura O; Kawauchi A; Fujito A; Mizutani Y; Okihara K; Mikami K; Soh J; Nakamura T; Nakanishi H; Ushijima S; Miki T
Int J Urol; 2004 Dec; 11(12):1051-7. PubMed ID: 15663674
[TBL] [Abstract][Full Text] [Related]
14. Intermediate oncological outcomes of percutaneous radiofrequency ablation for small renal tumors: initial experience.
Nitta Y; Tanaka T; Morimoto K; Makino T; Nishikawa N; Tashiro K; Naganuma T; Iguchi T; Matsuoka T; Nakatani T
Anticancer Res; 2012 Feb; 32(2):615-8. PubMed ID: 22287753
[TBL] [Abstract][Full Text] [Related]
15. Real-time virtual ultrasonographic radiofrequency ablation of renal cell carcinoma.
Ukimura O; Mitterberger M; Okihara K; Miki T; Pinggera GM; Neururer R; Peschel R; Aigner F; Gradl J; Bartsch G; Colleselli D; Strasser H; Pallwein L; Frauscher F
BJU Int; 2008 Mar; 101(6):707-11. PubMed ID: 18205858
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome.
Stern JM; Gupta A; Raman JD; Cost N; Lucas S; Lotan Y; Raj GV; Cadeddu JA
BJU Int; 2009 Sep; 104(6):786-9. PubMed ID: 19426196
[TBL] [Abstract][Full Text] [Related]
17. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.
Clark TW; Malkowicz B; Stavropoulos SW; Sanchez R; Soulen MC; Itkin M; Patel A; Mondschein JI; Wein AJ
J Vasc Interv Radiol; 2006 Mar; 17(3):513-9. PubMed ID: 16567676
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A
Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086
[TBL] [Abstract][Full Text] [Related]
20. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques.
Raman JD; Raj GV; Lucas SM; Williams SK; Lauer EM; Ahrar K; Matin SF; Leveillee RJ; Cadeddu JA
BJU Int; 2010 Feb; 105(4):496-500. PubMed ID: 19681900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
